Attention control in mood and anxiety disorders: Evidence from the antisaccade task

Human Psychopharmacology

Volumn 28, Issue 3, 2013, Pages 274-280

  Ainsworth, Ben ^a,b   Garner, Matthew ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

antisaccade task; anxiety; attention; cognitive inhibition

Indexed keywords

LORAZEPAM; MODAFINIL; NICOTINE; SERTRALINE;

ANTISACCADE TASK; ANXIETY DISORDER; ARTICLE; ATTENTION; BIPOLAR DISORDER; DRUG EFFECT; DYSPHORIA; EYE MOVEMENT; EYE TRACKING; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NEUROIMAGING; PERFORMANCE MEASUREMENT SYSTEM; PREFRONTAL CORTEX; PRIORITY JOURNAL; REACTION TIME; SCHIZOPHRENIA; SEPARATION ANXIETY; TRANSCRANIAL MAGNETIC STIMULATION; VISUAL STIMULATION;

ANXIETY DISORDERS; ATTENTION; EYE MOVEMENT MEASUREMENTS; HUMANS; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; SACCADES;

EID: 84878255344     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2320     Document Type: Article

References (38)

1. Ansari TL, Derakshan N, Richards A,. 2008. Effects of anxiety on task switching: evidence from the mixed antisaccade task. Cogn Affect Behav Ne 8: 229-238.
2. Ansari TL, Derakshan N,. 2011. The neural correlates of impaired inhibitory control in anxiety. Neuropsychologia 49: 1146-1153.
3. Ansari TL, Derakshan N,. 2010. Anxiety impairs inhibitory control but not volitional action control. Cognition Emotion 24: 241-254.
4. Bar-Haim Y, Lamy D, Pergamin L, Bakermans-Kranenburg MJ, Van IJzendoorn MH,. 2007. Threat-related attentional bias in anxious and nonanxious individuals: a meta-analytic study. Psychol Bull 133: 1-24.
5. Beck AT, Steer RA, Brown GK,. 1996. Manual for the Beck Depression Inventory-Second Edition (BDI-II). The Psychological Corporation: San Antonio, Texas.
6. Bishop SJ,. 2007. Neurocognitive mechanisms of anxiety: an integrative account. Trends Cogn Sci 11: 307-316.
7. Cornwell BR, Mueller SC, Kaplan R, Grillon C, Ernst M,. 2012. Anxiety, a benefit and detriment to cognition: behavioral and magnetoencephalographic evidence from a mixed-saccade task. Brain Cogn 78: 257-267.
8. Crevits L, Van den Abbeele D, Audenaert K, Goethals M, Dierick M,. 2005. Effect of repetitive transcranial magnetic stimulation on saccades in depression: a pilot study. Psychiat Res 135: 113-119.
9. De Lissnyder E, Derakshan N, De Raedt R, Koster EHW,. 2011. Depressive symptoms and cognitive control in a mixed antisaccade task: specific effects of depressive rumination. Cognition Emotion 25: 886-897.
10. De Raedt R, EHW Koster,. 2010. Understanding vulnerability for depression from a cognitive neuroscience perspective: a reappraisal of attentional factors and a new conceptual framework. Cogn Affect Behav Ne 10: 50-70.
11. Derakshan N, Ansari TL, Hansard M, Shoker L, Eysenck MW,. 2009a. Anxiety, inhibition, efficiency, and effectiveness. An investigation using antisaccade task. Exp Psychol, 56: 48-55.
12. Derakshan N, Salt M, Koster EHW,. 2009b. Attentional control in dysphoria: an investigation using the antisaccade task. Biol Psychol 80: 251-255.
13. Derryberry D, Reed AM,. 2002. Anxiety-related attentional biases and their regulation by attentional control. J Abnorm Psychol 111: 225-236.
14. Ettinger U, Ffytche DH, Kumari V, et al,. 2008. Decomposing the neural correlates of antisaccade eye movements using event-related FMRI. Cereb Cortex 18: 1148-1159.
15. Eysenck MW, Calvo MG,. 1992. Anxiety and performance: the processing efficiency theory. Cognition Emotion 6: 409-434.
16. Eysenck MW, Derakshan N,. 2011. New perspectives in attentional control theory. Pers Indiv Diff 50: 955-960.
17. Eysenck MW, Derakshan N, Santos R, Calvo MG, 2007. Anxiety and cognitive performance: attentional control theory. Emotion 7: 336-353.
18. Garner M, Ainsworth B, Gould H, Gardner H, Baldwin DS,. 2009. Impaired attentional control in high and low anxious healthy volunteers: evidence from the antisaccade task. Eur Neuropsychopharm 19: S599.
19. Garner M, Attwood A, Baldwin DS, James A, Munafò MR,. 2011. Inhalation of 7.5% carbon dioxide increases threat processing in humans. Neuropsychopharm 19: 1557-1562.
20. Green JF, King DJ,. 2000. Antisaccade and smooth pursuit eye movements in healthy subjects receiving sertraline and lorazepam. J Psychopharmacol, 14: 30-36.
21. Hakamata YS, Lissek S,. 2010. Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. Biol Psychiat 68: 982-990.
22. Harmer CJ, Goodwin GM, Cowen PJ,. 2009. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 195: 102-108.
23. Harris MSH, Reilly JL, Thase ME, Keshavan MS, Sweeney, AJ,. 2009. Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression. Psychiat Res 170: 150-156.
24. Hutley DR, Baker LD, Ainsworth B, Baldwin DS, Garner M,. 2010. Interactions between self-report attention control and anxiety on antisaccade performance. J Psychopharmacol 24: A79.
25. Hutton SB, Ettinger U,. 2006. The antisaccade task as a research tool in psychopathology□: A critical review, Psychophys 43: 302-313.
26. Jazbec S, McClure E, Hardin M, Pine DS, Ernst M,. 2005. Cognitive control under contingencies in anxious and depressed adolescents: an antisaccade task. Biol Psychiat 58: 632-639.
27. Katsanis J, Kortenkamp S, Iacono WG, Grove WM,. 1997. Antisaccade performance in patients with schizophrenia and affective disorder. J Abnormal Psychol, 106: 468-472.
28. Kristjánsson A, Chen Y, Nakayama K,. 2001. Less attention is more in the preparation of antisaccades, but not prosaccades. Nat Neurosci, 4: 1037-1042.
29. Malsert JM, Guyader N, Chauvin A, et al,. 2012. Antisaccades as a follow-up tool in major depressive disorder therapies: a pilot study. Psychiat Res 200: 1051-1053.
30. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD,. 2000. The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis. Cognitive Psychol 41: 49-100.
31. Pringle AM, Browning M,. 2011. A cognitive neuropsychological model of antidepressant drug action. Progress in Neuro-Psychoph 35: 1586-1592.
32. Reinholdt-Dunne ML, Mogg K, Benson V, et al,. 2012. Anxiety and selective attention to angry faces: an antisaccade study. J Cogn Psychol 24: 54-65.
33. Rycroft S, Rusted C,. 2007. Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison. Psychopharmacology 195: 245-253.
34. Shafiq-Antonacci R, Maruff P, Whyte S, Tyler P, Dudgeon P, Currie J,. 1999. The effects of age and mood on saccadic function in older individuals. J Gerontol B Psychol Sci Soc Sci, 54: P361-368.
35. Sylvester CM, Corbetta M, Raichle ME, et al,. 2012. Functional network dysfunction in anxiety and anxiety disorders. Trends Neurosci, 35: 527-535.
36. Smyrnis N, Evdokimidis I, Stefanis NC, et al,. 2003. Antisaccade performance of 1,273 men: effects of schizotypy, anxiety, and depression. J Abnorm Psychol 112: 403-414.
37. Spielberger CD, Gorusch RL, Lushene R, Vagg PR, Jacobs GA,. 1983. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press: Palo Alto, CA.
38. Sweeney JA, Strojwas MH, Mann JJ, Thase ME,. 1998. Prefrontal and cerebellar abnormalities in major depression: evidence from oculomotor studies. Biol Psychiat 43: 584-594.